This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, S.
Right arrow Articles by Billiar, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, S.
Right arrow Articles by Billiar, T. R.

 Previous Article  |  Next Article 

Infection and Immunity, November 1998, p. 5089-5098, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Expression of CD14 by Hepatocytes: Upregulation by Cytokines during Endotoxemia

Shubing Liu,1,* Lajwanti S. Khemlani,2 Richard A. Shapiro,1 Mark L. Johnson,1 Kaihong Liu,1 David A. Geller,1 Simon C. Watkins,3 Sanna M. Goyert,2 and Timothy R. Billiar1

Department of Surgery1 and Department of Cell Biology and Physiology,3 University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, and Division of Molecular Medicine, Department of Medicine, North Shore University Hospital-New York University, Manhasset, New York 110302

Received 15 October 1997/Returned for modification 5 December 1997/Accepted 6 August 1998

Studies were undertaken to examine hepatocyte CD14 expression during endotoxemia. Our results show that lipopolysaccharide (LPS) treatment in vivo caused a marked upregulation in CD14 mRNA and protein levels in rat hepatocytes. Detectable increases in mRNA were seen as early as 1.5 h after LPS treatment; these increases peaked at 20-fold by 3 h and returned to baseline levels by 24 h. In situ hybridization localized the CD14 mRNA expression to hepatocytes both in vitro and in vivo. Increases in hepatic CD14 protein levels were detectable by 3 h and peaked at 12 h. Hepatocytes from LPS-treated animals expressed greater amounts of cell-associated CD14 protein, and more of the soluble CD14 was released by hepatocytes from LPS-treated rats in vitro. The increases in hepatocyte CD14 expression during endotoxemia occurred in parallel to increases of CD14 levels in plasma. To provide molecular identification of the hepatocyte CD14, we cloned the rat liver CD14 cDNA. The longest clone consists of a 1,591-bp insert containing a 1,116-bp open reading frame. The deduced amino acid sequence is 372 amino acids long, has 81.8 and 62.8% homology to the amino acid sequences of mouse and human CD14, respectively, and is identical to the rat macrophage CD14. The expressed CD14 protein from this clone was functional, as indicated by NF-kappa B activation in response to LPS and fluorescein isothiocyanate-LPS binding in CHO cells stably transfected with rat CD14. A nuclear run-on assay showed that CD14 transcription rates were significantly increased in hepatocytes from LPS-treated animals, indicating that the upregulation in CD14 mRNA levels observed in rat hepatocytes after LPS treatment is dependent, in part, on increased transcription. In vitro and in vivo experiments indicated that interleukin-1beta and/or tumor necrosis factor alpha  participate in the upregulation of CD14 mRNA levels in hepatocytes. Our data indicate that hepatocytes express CD14 and that hepatocyte CD14 mRNA and protein levels increase rapidly during endotoxemia. Our observations also support the idea that soluble CD14 is an acute-phase protein and that hepatocytes could be a source for soluble CD14 production.

* Corresponding author. Mailing address: Department of Surgery, University of Pittsburgh, W1504 BST, Lothrop and Terrace Sts., Pittsburgh, PA 15261. Phone: (412) 624-6740. Fax: (412) 624-1172. E-mail: shubing{at}pitt.edu.

Infection and Immunity, November 1998, p. 5089-5098, Vol. 66, No. 11
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Scott, M. J., Billiar, T. R. (2008). {beta}2-Integrin-induced p38 MAPK Activation Is a Key Mediator in the CD14/TLR4/MD2-dependent Uptake of Lipopolysaccharide by Hepatocytes. J. Biol. Chem. 283: 29433-29446 [Abstract] [Full Text]  
  • Romics, L. Jr, Dolganiuc, A., Velayudham, A., Kodys, K., Mandrekar, P., Golenbock, D., Kurt-Jones, E., Szabo, G. (2005). Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes. J. Leukoc. Biol. 78: 1255-1264 [Abstract] [Full Text]  
  • Carotenuto, P., van Riel, D., Artsen, A., Bruijns, S., Uytdehaag, F. G., Laman, J. D., van Nunen, A. B., Zondervan, P. E., De Man, R. A., Osterhaus, A. D., Pontesilli, O. (2005). Antiviral Treatment with Alpha Interferon Up-Regulates CD14 on Liver Macrophages and Its Soluble Form in Patients with Chronic Hepatitis B. Antimicrob. Agents Chemother. 49: 590-599 [Abstract] [Full Text]  
  • Bas, S., Gauthier, B. R., Spenato, U., Stingelin, S., Gabay, C. (2004). CD14 Is an Acute-Phase Protein. J. Immunol. 172: 4470-4479 [Abstract] [Full Text]  
  • Van Amersfoort, E. S., Van Berkel, T. J. C., Kuiper, J. (2003). Receptors, Mediators, and Mechanisms Involved in Bacterial Sepsis and Septic Shock. Clin. Microbiol. Rev. 16: 379-414 [Abstract] [Full Text]  
  • Jirillo, E., Caccavo, D., Magrone, T., Piccigallo, E., Amati, L., Lembo, A., Kalis, C., Gumenscheimer, M. (2002). Review: The role of the liver in the response to LPS: experimental and clinical findings. Innate Immunity 8: 319-327 [Abstract]  
  • Su, G. L. (2002). Lipopolysaccharides in liver injury: molecular mechanisms of Kupffer cell activation. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G256-G265 [Abstract] [Full Text]  
  • Liu, S., Gallo, D. J., Green, A. M., Williams, D. L., Gong, X., Shapiro, R. A., Gambotto, A. A., Humphris, E. L., Vodovotz, Y., Billiar, T. R. (2002). Role of Toll-Like Receptors in Changes in Gene Expression and NF-{kappa}B Activation in Mouse Hepatocytes Stimulated with Lipopolysaccharide. Infect. Immun. 70: 3433-3442 [Abstract] [Full Text]  
  • Gonzalez, H. E., Eugenin, E. A., Garces, G., Solis, N., Pizarro, M., Accatino, L., Saez, J. C. (2002). Regulation of hepatic connexins in cholestasis: possible involvement of Kupffer cells and inflammatory mediators. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G991-G1001 [Abstract] [Full Text]  
  • Vodovotz, Y., Shubing Liu, , McCloskey, C., Shapiro, R., Green, A., Billiar, T. R. (2001). The hepatocyte as a microbial product-responsive cell. Innate Immunity 7: 365-373 [Abstract]  
  • Ferrari, L., Peng, N., Halpert, J. R., Morgan, E. T. (2001). Role of Nitric Oxide in Down-Regulation of CYP2B1 Protein, but Not RNA, in Primary Cultures of Rat Hepatocytes. Mol. Pharmacol. 60: 209-216 [Abstract] [Full Text]  
  • Morgan, E. T. (2001). Regulation of Cytochrome P450 by Inflammatory Mediators: Why and How?. Drug Metab. Dispos. 29: 207-212 [Abstract] [Full Text]  
  • Pan, Z., Zhou, L., Hetherington, C. J., Zhang, D.-E. (2000). Hepatocytes Contribute to Soluble CD14 Production, and CD14 Expression Is Differentially Regulated in Hepatocytes and Monocytes. J. Biol. Chem. 275: 36430-36435 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»